메뉴 건너뛰기




Volumn 8, Issue 7, 2012, Pages 617-619

8th International Congress on Autoimmunity: New perspectives for refractory catastrophic antiphospholipid syndrome

Author keywords

antiphospholipid antibodies; autoimmunity; defibrotide; eculizumab; rituximab

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DEFIBROTIDE; DIPYRIDAMOLE; ECULIZUMAB; GLUCOCORTICOID; HEPARIN; IMMUNOGLOBULIN; RITUXIMAB;

EID: 84867749740     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.48     Document Type: Conference Paper
Times cited : (8)

References (16)
  • 1
    • 84861342502 scopus 로고    scopus 로고
    • Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry"
    • Cervera R, Espinosa G. Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry". Semin. Thromb. Hemost. 38(4), 333-338 (2012).
    • (2012) Semin. Thromb. Hemost. , vol.38 , Issue.4 , pp. 333-338
    • Cervera, R.1    Espinosa, G.2
  • 2
    • 84861551121 scopus 로고    scopus 로고
    • CAPS registry
    • Cervera R. CAPS Registry. Lupus 21(7), 755-757 (2012).
    • (2012) Lupus , vol.21 , Issue.7 , pp. 755-757
    • Cervera, R.1
  • 3
    • 80052263703 scopus 로고    scopus 로고
    • Management of refractory cases of catastrophic antiphospholipid syndrome
    • Espinosa G, Berman H, Cervera R. Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmun. Rev. 10(11), 664-668 (2011).
    • (2011) Autoimmun. Rev. , vol.10 , Issue.11 , pp. 664-668
    • Espinosa, G.1    Berman, H.2    Cervera, R.3
  • 6
    • 84886948854 scopus 로고    scopus 로고
    • Relapsing catastrophic antiphospholipid syndrome: Potential role of microangiopathic hemolytic anemia in disease relapses
    • for the CAPS Registry Project Group (European Forum on Antiphospholipid Antibodies) doi:10.1016/j.semarthrit.2012.05.005 Epub ahead of print)
    • Espinosa G, Rodríguez-Pintó I, Gómez-Puerta JA, Pons-Estel G, Cervera R, for the CAPS Registry Project Group (European Forum on Antiphospholipid Antibodies). Relapsing catastrophic antiphospholipid syndrome: Potential role of microangiopathic hemolytic anemia in disease relapses. Semin. Arthritis Rheum. doi:10.1016/j.semarthrit.2012.05.005 (2012) (Epub ahead of print).
    • (2012) Semin. Arthritis Rheum.
    • Espinosa, G.1    Rodríguez-Pintó, I.2    Gómez-Puerta, J.A.3    Pons-Estel, G.4    Cervera, R.5
  • 8
    • 45549093797 scopus 로고    scopus 로고
    • Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginalzone lymphoma with low-molecular weight heparin, rituximab and bendamustine
    • Manner H, Jung B, Tonassi L et al. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginalzone lymphoma with low-molecular weight heparin, rituximab and bendamustine. Am. J. Med. Sci. 335(5), 394-397 (2008).
    • (2008) Am. J. Med. Sci. , vol.335 , Issue.5 , pp. 394-397
    • Manner, H.1    Jung, B.2    Tonassi, L.3
  • 10
    • 62449319386 scopus 로고    scopus 로고
    • Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome
    • Nageswara Rao AA, Arteaga GM, Reed AM, Gloor JM, Rodriguez V. Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome. Pediatr. Blood Cancer 52(4), 536-538 (2009).
    • (2009) Pediatr. Blood Cancer , vol.52 , Issue.4 , pp. 536-538
    • Nageswara Rao, A.A.1    Arteaga, G.M.2    Reed, A.M.3    Gloor, J.M.4    Rodriguez, V.5
  • 11
    • 77649213188 scopus 로고    scopus 로고
    • Catastrophic antiphospholipid syndrome and rituximab: A new report
    • Jamoussi SK, Zaghdoudi I, Ben Dhaou B, et al. Catastrophic antiphospholipid syndrome and rituximab: A new report. Tunis Med. 87, 699-702 (2009).
    • (2009) Tunis Med. , vol.87 , pp. 699-702
    • Jamoussi, S.K.1    Zaghdoudi, I.2    Ben Dhaou, B.3
  • 13
    • 77951025811 scopus 로고    scopus 로고
    • Osteonecrosis secondary to antiphospholipid syndrome: A case report, review of the literature, and treatment strategy
    • Haque W, Kadikoy H, Pacha O, Maliakkal J, Hoang V, Abdellatif A. Osteonecrosis secondary to antiphospholipid syndrome: A case report, review of the literature, and treatment strategy. Rheumatol. Int. 30(6), 719-723 (2010).
    • (2010) Rheumatol. Int. , vol.30 , Issue.6 , pp. 719-723
    • Haque, W.1    Kadikoy, H.2    Pacha, O.3    Maliakkal, J.4    Hoang, V.5    Abdellatif, A.6
  • 14
    • 0036732005 scopus 로고    scopus 로고
    • Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator
    • Burcoglu-O'Ral A, Erkan D, Asherson R. Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator. J. Rheumatol. 29(9), 2006-2011 (2002). (Pubitemid 34988713)
    • (2002) Journal of Rheumatology , vol.29 , Issue.9 , pp. 2006-2011
    • Burcoglu-O'Ral, A.1    Erkan, D.2    Asherson, R.3
  • 16
    • 77951853702 scopus 로고    scopus 로고
    • Eculizumab and renal transplantation in a patient with CAPS
    • Lonze BE, Singer AL, Montgomery RA. Eculizumab and renal transplantation in a patient with CAPS. N. Engl. J. Med. 362(18), 1744-1745 (2010).
    • (2010) N. Engl. J. Med. , vol.362 , Issue.18 , pp. 1744-1745
    • Lonze, B.E.1    Singer, A.L.2    Montgomery, R.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.